As demonstrated by a previous publication, REGNASE-1 deficiency reprograms CD8+ T cells in the tumor by enhancing BATF, resulting in improving mitochondrial metabolism, which is reversed upon BATF deletion [33]. This evidence concerns the gene CD8A and neoplasm.